Global timing of hepatitis C virus elimination in high-income countries
- PMID: 31815353
- DOI: 10.1111/liv.14324
Global timing of hepatitis C virus elimination in high-income countries
Abstract
Background & aims: Introduction of highly efficacious pan-genotypic therapies for hepatitis C virus (HCV) infection has made the elimination of the disease an attainable goal. This study assessed progress made in 45 high-income countries towards meeting the World Health Organization's targets for HCV elimination by 2030.
Methods: A Markov model developed to forecast annual HCV-infected population was populated with demographic and epidemiological inputs, with historical incidence calibrated to reported prevalence of chronic HCV for each country. Future incidence was assumed to be a linear function of overall prevalence (or prevalence of minimal fibrosis in countries with treatment restrictions). 2017 levels of diagnosis and treatment were assumed constant in the future. The analysis estimated the year countries would meet HCV elimination targets for 80% reduction in incidence, 65% reduction in liver-related deaths, 90% diagnosis coverage and 80% treatment among the treatment-eligible population.
Results: Of the 45 countries analyzed, nine (Australia, France, Iceland, Italy, Japan, South Korea, Spain, Switzerland and the United Kingdom) are on track towards meeting the HCV elimination targets by 2030. While Austria, Germany and Malta could also reach the targets with expanded screening efforts, 30 countries are not projected to eliminate HCV before 2050. Incidence was the most difficult target to achieve, followed by liver-related deaths.
Conclusions: Even with introduction of curative therapies, 80% of high-income countries are not on track to meet HCV elimination targets by 2030, and 67% are off track by at least 20 years. Immediate action to improve HCV screening and treatment is needed globally to make HCV elimination attainable.
Keywords: Hepatitis C; elimination; global.
© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Comment in
-
Taiwan is on track of accelerating hepatitis C elimination by 2025.Liver Int. 2020 Jun;40(6):1506-1507. doi: 10.1111/liv.14412. Epub 2020 Mar 8. Liver Int. 2020. PMID: 32086990 No abstract available.
-
Response to Taiwan is on track of accelerating hepatitis C elimination by 2025.Liver Int. 2020 Jun;40(6):1507. doi: 10.1111/liv.14457. Epub 2020 Apr 24. Liver Int. 2020. PMID: 32329552 No abstract available.
References
REFERENCES
-
- WHO. Combating Hepatitis B and C to Reach Elimination by 2030. Geneva, Switzerland: Author; 2016.
-
- WHO. Global Health Sector Strategy on Viral Hepatitis, 2016-2021, Towards Ending Viral Hepatitis. Geneva, Switzerland: Author; 2016.
-
- Wedemeyer H, Duberg AS, Buti M, et al. Strategies to manage hepatitis C virus (HCV) disease burden. J Viral Hepat. 2014;21(Suppl 1):60-89.
-
- Blach S, Zeuzem S, Manns M, et al. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study. Lancet Gastroenterol Hepatol. 2016;2(3):161-176.
-
- The World Bank. World Bank Country and Lending Groups. 2019. https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-b...
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical